Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats

European Journal of Pharmacology

Volumn 309, Issue 2, 1996, Pages 121-130

  Riekkinen Jr , Paavo ^a   Schmidt, Bernard ^b   Stefanski, Roman ^a   Kuitunen, Jani ^a   Riekkinen, Minna ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Institute for Neurobiology   (Germany)

Author keywords

Aging; Medial septum lesion; Metrifonate; Passive avoidance; Scopolamine; Spatial navigation

Indexed keywords

CHOLINESTERASE INHIBITOR; METRIFONATE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SPATIAL ORIENTATION;

EID: 0030575536     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00336-6     Document Type: Article

References (40)

1. Bartus, R.T., 1979, Physostigmine and recent memory: effects in young and aged non-human primates, Science 206, 1087.
2. Battus, R.T., R.L. Dean, M.J. Pontecorvo and C. Flicker, 1985, The cholinergic hypothesis: a historical overview, current perspective, and future directions, Ann. NY Acad. Sci. 444, 332.
3. Bassant, M., H., F, Poindessous and Y. Lamour, 1995, Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats, Soc. Neurosci. Abstr. 237, 12.
4. Becker, R.E. and E. Giacobini, 1988, Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects, Drug Dev. Res. 12, 163.
5. Blokland, A., V. Hinz, I. Gebert, B. Armah, F.J. Van der Staay and B. Schmidt, 1996, Effects of metrifonate and tacrine in the spatial Morris maze task and modified Irwin test: evaluation of the efficacy/safety profile in rats. Drug Dev. Res. 36, 166.
6. Bowen, D.M., S.J. Allen, J.S. Benton, M.J. Goodhardt, E.A. Haan, A.M. Palmer, N.R. Sims, C.C.T. Smith, J.A. Spillane, G.K. Esira, D. Neary, J.S. Snowden, G.K. Wilcock and A.N. Davison, 1983, Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease, J. Neurochem. 41, 266.
7. Bowen, D.M. and A.N. Davison, 1986, Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease, Br. Med. Bull. 42, 75.
8. Bowen, D.M., P.T. Francis, M.N. Pangalos, P.H. Stephens, A.W. Procter and I.P. Chessell, 1992, 'Traditional' pharmacotherapy may succeed in Alzheimer's disease, Trends Neurosci. 15, 84.
9. Byrne, E.J. and T. Arie, 1994, Tetrahydroaminoacridine and Alzheimer's disease. For the few, but we don't know which few, Br. Med. J. 308, 868.
10. Decker, M.W., 1987, The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system, Brain Res. Rev. 12, 423.
11. Decker, M.W. and J.L. McGaugh, 1991, The role of interactions between cholinergic system and other neuromodulatory systems in learning and memory, Synapse 7, 151.
12. Dunnett, S.B. and H.C. Fibiger, 1993, Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia, Prog. Brain Res. 98, 413.
13. Dunnett, S.B., B.J. Everitt and T.W. Robbins, 1991, The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions, Trends Neurosci. 14, 494.
14. Eagger, S.A., R. Levy and B.J. Sahakian, 1991, Tacrine in Alzheimer's disease, Lancet 337, 989.
15. Eagger, S., N. Morant, R. Levy and B. Sahakian, 1992, Tacrine in Alzheimer's disease. Time course of changes in cognitive function and practice effects, Br. J. Psychiatry 160, 36.
16. Fibiger, H.C., 1991, Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence, Trends Neurosci. 14, 220.
17. Fonnum, F., 1975, A rapid radiochemical method of the determinaton of choline acetyltransferase, J. Neurochem. 24, 707.
18. Hagan, J.J. and R.G.M. Morris, 1988, The cholinergic hypothesis of memory: a review of animal experiments, in: Psychopharmacology of the Aging Nervous System, eds. L.L. Iversen, S.D. Iversen and S.H. Snyder (Plenum, New York) p. 237.
19. Hinz, V., 1995.
20. Hinz, V., S. Grewig and B.H. Schmidt, 1996a, Metrifonate and dichlorovos: effects fo a single oral administraton on cholinesterase activity in rat brain and blood, Neurochem. Res. in press.
21. Hinz, V., S. Grewig and B.H. Schmidt, 1996b, Metrifonate induced cholinesterase inhibition exclusively via slow release of dichlorovos, Neurochem. Res. in press.
22. Holmstedt, B., I. Nordgren, M. Sandoz and A. Sundwall, 1978. Metrifonate. Summary of toxicological and pharmacological information available, Arch. Toxicol. 41, 3-29.
23. Knapp, M.J., D.S. Knopman, P.R. Solomon, W.W. Pendlebury, C.S. Davis and S.I. Gracon, 1992, A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease, JAMA 271, 985.
24. Kronforst, M.A., P.L. Moriearty, M. Ralphs, R.E. Becker, B. Schmidt, L.T. Thompson and J.F. Disterhopt, 1995, Facilitation of learning in the aging rabbit after chronic metrifonate treatment, Soc. Neurosci. Abstr. 82.3, page 196.
25. Levine, E.D., 1992, Nicotinic systems and cognitive function, Psychopharmacology (Berlin) 108, 417.
26. Miettinen, R., J. Sirviö, P. Riekkinen Sr., M. Laakso, M. Riekkinen and P. Riekkinen Jr., 1993, Neocortical, hippocampal and septum parvalbumin- and somatostatin-containing neurons in young and aged rats: correlation with passive avoidance and water maze performance, Neuroscience 53, 367.
27. Mori, F., G. Cuadara and E. Giacobini, 1995, Metrifnate effects on acetylcholine and biogenic amines in rat cortex, Neurochem. Res. 20, 1081.
28. Nabeshima, T., A. Nitta, A, Itoh, Y. Katono and T. Hasegawa T, 1995, Effects of metrifonate on impairment of learning, memory and acetylcholine release induced by scopolamine and basal forebrain lesion in rats. Abstr., 55th F.I.P. Congress, Stockholm, Sweden.
29. Nordgren, I., M. Bergstrom, B. Holmstedt and M. Sandoz, 1978, Transformation and action of metrifonate, Arch. Toxicol. 71, 31.
30. Parson, D.E., A. Peagler, T.S. Barlow and L.E. Harrell, 1987, Failure of chronic physostigmine to amelioriate working memory deficits after medial septum lesions, Exp. Neurol. 96, 456.
31. Reiner, E., B. Krautchacker, V. Simeon and M. Skrinjaric-Spoîjar, 1975, Mechanisms of action of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of 0,0-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphonate (Trichlorphon), Biochem. Pharmcol. 24, 717.
32. Riekkinen, P. Jr., J. Sirviö and P. Riekkinen, 1990, The effects of Tacrine on medial septum lesion-induced memory defects, Pharmacol. Biochem. Behav. 36, 237.
33. Riekkinen, P. Jr., M. Aaltonen, J. Sirviö and P. Riekkinen, 1991a, Tetrahydroaminoacridine alleviates medial septum lesion-induced and age-related spatial reference but not working memory deficits, Physiol. Behav. 49, 1147.
34. Riekkinen, P. Jr., M. Riekkinen, H. Lahtinen, J. Sirviö, A. Valjakka and P. Riekkinen, 1991b, Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septum lesion but not by fimbria-fornix lesion. Brain Res. Bull. 27, 587.
35. Riekkinen, P. Jr., J. Sirviö and M. Riekkinen, 1994, Serotonin depletion decreases the therapeutic effect of nicotine, but not Tacrine, in medial septum-Jesioned rats. Brain Res. 662, 95.
36. Sirviö, J., M. Harju, P. Riekkinen Jr., A. Haapalinna and P. Riekkinen, 1992, Comparative effects of alpha-2 receptor agent and THA on the performance of adult and aged rats in the delayed non-matching to position task. Psychopharmacology 109, 127.
37. Van der Staay F.J., V.C. Hinz and B.H. Schmidt, 1996, Effects of metrifonate on escape and avoidance learning in young and aged rats, Behav. Pharmacol. 6, 1.
38. Watkins, P.B., H.J. Zimmerman, M.J. Knapp, S.I. Gracon and K.W. Lewis, 1994, Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease, JAMA 271, 991.
39. Wenk, G.L., 1993, A primate model of Alzheimer's disease, Behav. Brain Res. 57, 117.
40. Whitehouse, P.J., D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle and R.M. DeLong, 1982, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science 215, 1237.